Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Sartorius Stedim Biotech SA
OTC:SDMHF
Sartorius Stedim Biotech SA
OTC:SDMHF
Price:
244
USD
Market Cap:
$23.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Sartorius Stedim Biotech SA
OTC:SDMHF
|
FR |
|
Bausch + Lomb Corp
NYSE:BLCO
|
CA |
|
A
|
Antofagasta PLC
XMUN:FG1
|
UK |
|
Caravel Minerals Ltd
ASX:CVV
|
AU |
|
Holding Company ADMIE IPTO SA
LSE:0RQM
|
GR |
|
Chengdu Easton Biopharmaceuticals Co Ltd
SSE:688513
|
CN |
|
7
|
707 Cayman Holdings Ltd
NASDAQ:JEM
|
HK |
|
APA Corp (US)
F:2S3
|
US |
|
Empire Company Ltd
TSX:EMP.A
|
CA |
Wall St Price Targets
SDMHF Price Forecast
Based on 15 analysts
Based on 15 analysts
+18% Upside
from
$244
today
Sartorius Stedim Biotech SA (SDMHF)’s 12-month stock price forecast through September 2027 has a consensus target of $289.07, implying 18% upside. The forecast is based on price targets from 15 Wall Street analysts.
SDMHF Analyst Rating
No ratings yet
No ratings yet
Sartorius Stedim Biotech SA Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SDMHF's stock price target?
Price Target
289.07
USD
289.07
USD
According to Wall Street analysts, the average 1-year price target for SDMHF is 289.07 USD with a low forecast of 248.59 USD and a high forecast of 325.53 USD.
What is the Revenue forecast for Sartorius Stedim Biotech SA?
Projected CAGR
11%
11%
Over the last 13 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 8 years is 11%.
What is the Gross Profit forecast for Sartorius Stedim Biotech SA?
Projected CAGR
13%
13%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 13%. The projected CAGR for the next 5 years is 13%.
What is the Operating Income forecast for Sartorius Stedim Biotech SA?
Projected CAGR
17%
17%
Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 8 years is 17%.
What is the Pre-Tax Income forecast for Sartorius Stedim Biotech SA?
Projected CAGR
34%
34%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 12%. The projected CAGR for the next 3 years is 34%.
What is the Net Income forecast for Sartorius Stedim Biotech SA?
Projected CAGR
24%
24%
Over the last 13 years, the compound annual growth rate for Net Income has been 13%. The projected CAGR for the next 8 years is 24%.